Differential in vivo activity of docetaxel plus PS-341 combination therapy in non-small cell lung carcinoma (NSCLC) xenografts.

被引：0
作者：
Gumerlock, PH [1 ]
Kimura, T [1 ]
Holland, WS [1 ]
Shih, CDD [1 ]
Lara, PN [1 ]
Gandara, DR [1 ]
机构：
[1] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7144
引用
收藏
页码：652S / 652S
页数：1
相关论文
共 50 条
  • [31] Phase II study of bevacizumab in combination with docetaxel and carboplatin in patients with metastatic non-small cell lung cancer (NSCLC)
    William, W. N., Jr.
    Kies, M. S.
    Fossella, F. V.
    Gladish, G.
    Heymach, J. V.
    Glisson, B. S.
    Tse, W. H.
    Liu, D.
    Herbst, R. S.
    Lippman, S. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Docetaxel (Taxotere®):: Current clinical development in non-small cell lung cancer (NSCLC)
    Manegold, C
    MEDIZINISCHE KLINIK, 1998, 93 (09) : A16 - A21
  • [33] Targeted Therapy in non-small cell Lung Carcinoma
    Tessmer, Antje
    Kollmeier, Jens
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (05) : 324 - 330
  • [34] MONOTOTAL-MARKER FOR NON-SMALL CELL LUNG CARCINOMA (NSCLC)
    Prazakova, M.
    Topolcan, O.
    Svobodova, S.
    Vrzalova, J.
    Pecen, L.
    Krakorova, G.
    Treska, V.
    Spisakova, M.
    Holubec, L., Jr.
    Pesek, M.
    TUMOR BIOLOGY, 2010, 31 : S48 - S48
  • [35] microRNAs as a Tool for the Subtyping of Non-Small Cell Lung Carcinoma (NSCLC).
    Cabanas, M. L.
    Navarro, A.
    Marrades, R.
    Campayo, M.
    Vinolas, N.
    Diaz, T.
    Monzo, M.
    Ramirez, J.
    LABORATORY INVESTIGATION, 2011, 91 : 406A - 406A
  • [36] Cisplatin in combination with 5-fluorouracil and epirubicin in advanced non-small cell lung carcinoma (NSCLC)
    Khodadad, K
    Shamshirsaz, AA
    Azadi, A
    Aghili, N
    Karimi, S
    Tahbaz, M
    LUNG CANCER, 2005, 49 : S251 - S252
  • [37] microRNAs as a Tool for the Subtyping of Non-Small Cell Lung Carcinoma (NSCLC)
    Cabanas, M. L.
    Navarro, A.
    Marrades, R.
    Campayo, M.
    Vinolas, N.
    Diaz, T.
    Monzo, M.
    Ramirez, J.
    MODERN PATHOLOGY, 2011, 24 : 406A - 406A
  • [38] Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer
    Adjei, AA
    Argiris, A
    Murren, JR
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 32 - 40
  • [39] Overview of docetaxel (Taxotere)/cisplatin combination in non-small cell lung cancer
    Le Chevalier, T
    Bérille, J
    Zalcberg, JR
    Millward, MJ
    Monnier, A
    Douillard, JY
    McKeage, MJ
    James, R
    Soulas, F
    Loret, C
    Bougon, N
    Bizzari, JP
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 13 - 18
  • [40] Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
    W. Schuette
    I. Bork
    B. Wollschläger
    S. Schädlich
    Clinical Drug Investigation, 2001, 21 : 161 - 168
12345